CVS Health Corporation $CVS Shares Sold by NorthCrest Asset Manangement LLC

NorthCrest Asset Manangement LLC decreased its stake in CVS Health Corporation (NYSE:CVS) by 54.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 41,376 shares of the pharmacy operator’s stock after selling 48,921 shares during the period. NorthCrest Asset Manangement LLC’s holdings in CVS Health were worth $3,191,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Exchange Traded Concepts LLC increased its position in CVS Health by 26.3% in the 2nd quarter. Exchange Traded Concepts LLC now owns 18,371 shares of the pharmacy operator’s stock valued at $1,267,000 after acquiring an additional 3,829 shares during the period. Diversified Trust Co increased its holdings in shares of CVS Health by 69.3% during the second quarter. Diversified Trust Co now owns 7,370 shares of the pharmacy operator’s stock valued at $508,000 after purchasing an additional 3,018 shares during the period. Sowell Financial Services LLC lifted its holdings in CVS Health by 58.2% in the second quarter. Sowell Financial Services LLC now owns 37,220 shares of the pharmacy operator’s stock worth $2,567,000 after purchasing an additional 13,697 shares during the period. Park Avenue Securities LLC grew its position in CVS Health by 72.4% in the 2nd quarter. Park Avenue Securities LLC now owns 44,641 shares of the pharmacy operator’s stock valued at $3,079,000 after buying an additional 18,751 shares in the last quarter. Finally, Farmers & Merchants Investments Inc. increased its stake in CVS Health by 1.7% during the 2nd quarter. Farmers & Merchants Investments Inc. now owns 266,774 shares of the pharmacy operator’s stock valued at $18,402,000 after buying an additional 4,430 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Performance

Shares of NYSE CVS opened at $78.51 on Tuesday. CVS Health Corporation has a 52-week low of $51.79 and a 52-week high of $85.15. The stock has a market capitalization of $99.66 billion, a price-to-earnings ratio of 206.61, a PEG ratio of 0.72 and a beta of 0.48. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. The stock’s fifty day simple moving average is $78.85 and its 200 day simple moving average is $74.42.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.CVS Health’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the company posted $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s payout ratio is currently 700.00%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on CVS. Wolfe Research increased their price objective on shares of CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, December 8th. TD Cowen upped their target price on CVS Health from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. Jefferies Financial Group lifted their price target on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Sanford C. Bernstein restated a “market perform” rating and issued a $91.00 price objective on shares of CVS Health in a report on Tuesday, January 6th. Finally, JPMorgan Chase & Co. raised their target price on CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research note on Wednesday, December 17th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.86.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.